BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhu YZ, Qian XJ, Zhao P, Qi ZT. How hepatitis C virus invades hepatocytes: The mystery of viral entry. World J Gastroenterol 2014; 20(13): 3457-3467 [PMID: 24707128 DOI: 10.3748/wjg.v20.i13.3457]
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3457.htm
Number Citing Articles
1
I. T. Shawa, D. J. Felmlee, D. Hegazy, D. A. Sheridan, M. E. Cramp. Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug usersJournal of Viral Hepatitis 2017; 24(12): 1082 doi: 10.1111/jvh.12720
2
Catalina Mihai, Bogdan Mihai, Anca Trifan, Carol Stanciu, Liana Gheorghe, Mircea Diculescu, Manuela Curescu, Ciprian Brisc, Adrian Goldis, Simona Bataga, Larisa Sandulescu, Ion Rogoveanu, Andrada Seicean, Cristina Cijevschi Prelipcean. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral TherapyHepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.58022
3
Nora A. Fierro, Evelyn Rivera-Toledo, Fernanda Ávila-Horta, Julio Y. Anaya-Covarrubias, Fela Mendlovic. Scavenger Receptors in the Pathogenesis of Viral InfectionsViral Immunology 2022; 35(3): 175 doi: 10.1089/vim.2021.0167
4
Jens Mattern, Christian S. Roghi, Melanie Hurtz, Vera Knäuper, Dylan R. Edwards, Zaruhi Poghosyan. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cellsScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49021-3
5
Wen-Jun Shen, Salman Azhar, Fredric B. Kraemer. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and EffluxAnnual Review of Physiology 2018; 80(1): 95 doi: 10.1146/annurev-physiol-021317-121550
6
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections2020; : 107 doi: 10.1007/978-3-030-02200-6_6
7
Qiu Pan, Yan Xie, Ying Zhang, Xinqi Guo, Jing Wang, Min Liu, Xiao-Lian Zhang. EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defensesNature Communications 2024; 15(1) doi: 10.1038/s41467-024-44960-6
8
Clementina Sansone, Christophe Brunet, Douglas M. Noonan, Adriana Albini. Marine Algal Antioxidants as Potential Vectors for Controlling Viral DiseasesAntioxidants 2020; 9(5): 392 doi: 10.3390/antiox9050392
9
J Alfredo Martínez, Marta Alonso-Bernáldez, Diego Martínez-Urbistondo, Juan A Vargas-Nuñez, Ana Ramírez de Molina, Alberto Dávalos, Omar Ramos-Lopez. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseasesWorld Journal of Gastroenterology 2022; 28(44): 6230-6248 doi: 10.3748/wjg.v28.i44.6230
10
J Ampuero, J A del Campo, L Rojas, R J García-Lozano, M Buti, R Solá, X Forns, R Moreno-Otero, R Andrade, M Diago, J Salmerón, L Rodrigo, J A Pons, J M Navarro, J L Calleja, J García-Samaniego, M García-Valdecasas, Á Rojas, R Millán, M F González-Escribano, M Romero-Gómez. Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infectionGenes & Immunity 2015; 16(5): 297 doi: 10.1038/gene.2015.14
11
Artur Yakimovich, Vardan Andriasyan, Robert Witte, I-Hsuan Wang, Vibhu Prasad, Maarit Suomalainen, Urs F. Greber, Oliver Schildgen. Plaque2.0—A High-Throughput Analysis Framework to Score Virus-Cell Transmission and Clonal Cell ExpansionPLOS ONE 2015; 10(9): e0138760 doi: 10.1371/journal.pone.0138760
12
Ngan N. T. Nguyen, Yun-Sook Lim, Lap P. Nguyen, Si C. Tran, Trang T. D. Luong, Tram T. T. Nguyen, Hang T. Pham, Han N. Mai, Jae-Woong Choi, Sang-Seop Han, Soon B. Hwang. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral PropagationScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33861-6
13
Otsubo Ryota, Teruhito Yasui. Monoclonal Antibody Therapeutics for Infectious Diseases: Beyond Normal Human ImmunoglobulinSSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4022365
14
Yunyun Wang, Jing Wang, Shanshan Wu, Haihong Zhu. The unexpected structures of hepatitis C virus envelope proteinsExperimental and Therapeutic Medicine 2017; 14(3): 1859 doi: 10.3892/etm.2017.4745
15
Chun-Chun Chang, Hao-Jen Hsu, Jui-Hung Yen, Shih-Yen Lo, Je-Wen Liou, Chiaho Shih. A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81PLOS ONE 2017; 12(5): e0177383 doi: 10.1371/journal.pone.0177383
16
Heather Ezelle, Krishnamurthy Malathi, Bret Hassel. The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate ResponseInternational Journal of Molecular Sciences 2016; 17(1): 74 doi: 10.3390/ijms17010074
17
Matteo Castelli, Nicola Clementi, Giuseppe A. Sautto, Jennifer Pfaff, Kristen M. Kahle, Trevor Barnes, Benjamin J. Doranz, Matteo Dal Peraro, Massimo Clementi, Roberto Burioni, Nicasio Mancini. HCV E2 core structures and mAbs: something is still missingDrug Discovery Today 2014; 19(12): 1964 doi: 10.1016/j.drudis.2014.08.011
18
David Balgoma, Luis Gil-de-Gómez, Olimpio Montero. Lipidomics Issues on Human Positive ssRNA Virus Infection: An UpdateMetabolites 2020; 10(9): 356 doi: 10.3390/metabo10090356
19
Tejabhiram Yadavalli, Ipsita Volety, Deepak Shukla. Aptamers in Virology—A Consolidated Review of the Most Recent Advancements in Diagnosis and TherapyPharmaceutics 2021; 13(10): 1646 doi: 10.3390/pharmaceutics13101646
20
Dan Dong, Wei Xie, Min Liu. Alteration of cell junctions during viral infectionThoracic Cancer 2020; 11(3): 519 doi: 10.1111/1759-7714.13344
21
Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Piérard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M. Rodrigues, Tamara Vanhaecke. Infections at the nexus of metabolic-associated fatty liver diseaseArchives of Toxicology 2021; 95(7): 2235 doi: 10.1007/s00204-021-03069-1
22
Ryan P McNamara, Dirk P Dittmer. Extracellular vesicles in virus infection and pathogenesisCurrent Opinion in Virology 2020; 44: 129 doi: 10.1016/j.coviro.2020.07.014
23
Trang H. Au, Christopher J. Destache, Renuga Vivekanandan. Hepatitis C therapy: Looking toward interferon-sparing regimensJournal of the American Pharmacists Association 2015; 55(2): e72 doi: 10.1331/JAPhA.2015.15508
24
Laura-Sophie Beier, Jan Rossa, Stephen Woodhouse, Sophia Bergmann, Holger Kramer, Jonas Protze, Miriam Eichner, Anna Piontek, Sabine Vidal-y-Sy, Johanna Brandner, Gerd Krause, Nicole Zitzmann, Jörg Piontek. Use of Modified Clostridium perfringens Enterotoxin Fragments for Claudin Targeting in Liver and Skin CellsInternational Journal of Molecular Sciences 2019; 20(19): 4774 doi: 10.3390/ijms20194774
25
Xiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, Kenta Yoshida, James Steven Leeder, Dwaipayan Mukherjee, Kunal Taskar, Manthena V. S. Varma, Xinyuan Zhang, Xinning Yang, Aleksandra Galetin. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC PerspectiveClinical Pharmacology & Therapeutics 2022; 112(3): 501 doi: 10.1002/cpt.2643
26
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
27
Charline Herrscher, Philippe Roingeard, Emmanuelle Blanchard. Hepatitis B Virus Entry into CellsCells 2020; 9(6): 1486 doi: 10.3390/cells9061486
28
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
29
Kun Zhao, Zhe Wang, Thilo Hackert, Claudia Pitzer, Margot Zöller. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progressionJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0961-6
30
Justin O. Ortiz, Jeffrey B. Brown, Ajay K. Varadhan, Charles Preuss. Infectious Diseases Drug Delivery Systems2023; : 51 doi: 10.1007/978-3-031-20521-7_3
31
Evgeny Knyazev, Stepan Nersisyan, Alexander Tonevitsky. Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue BarriersFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.636966
32
David Tarin. Understanding Cancer2023; : 229 doi: 10.1007/978-3-030-97393-3_9
33
Nejat Düzgüneş, Narcis Fernandez-Fuentes, Krystyna Konopka. Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide DesignPathogens 2021; 10(12): 1599 doi: 10.3390/pathogens10121599
34
ROBERT S. EGERMAN. New Antiviral Agents for Treatment of Hepatitis CClinical Obstetrics & Gynecology 2019; 62(4): 823 doi: 10.1097/GRF.0000000000000457
35
Matteo Castelli, Nicola Clementi, Jennifer Pfaff, Giuseppe A. Sautto, Roberta A. Diotti, Roberto Burioni, Benjamin J. Doranz, Matteo Dal Peraro, Massimo Clementi, Nicasio Mancini. A Biologically-validated HCV E1E2 Heterodimer Structural ModelScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00320-7
36
Yoshio Aizawa, Nobuyoshi Seki, Tomohisa Nagano, Hiroshi Abe. Chronic hepatitis C virus infection and lipoprotein metabolismWorld Journal of Gastroenterology 2015; 21(36): 10299-10313 doi: 10.3748/wjg.v21.i36.10299
37
Xi-Jing Qian, Xiao-Lian Zhang, Ping Zhao, Yong-Sheng Jin, Hai-Sheng Chen, Qing-Qiang Xu, Hao Ren, Shi-Ying Zhu, Hai-Lin Tang, Yong-Zhe Zhu, Zhong-Tian Qi. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human HepatocytesScientific Reports 2016; 6(1) doi: 10.1038/srep27268
38
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari, Piyush Kumar Gupta. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic EntitiesMolecular Pharmaceutics 2023; 20(8): 3698 doi: 10.1021/acs.molpharmaceut.2c01080
39
Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr VirusCancers 2023; 15(20): 4993 doi: 10.3390/cancers15204993
40
Ryota Otsubo, Teruhito Yasui. Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulinPharmacology & Therapeutics 2022; 240: 108233 doi: 10.1016/j.pharmthera.2022.108233
41
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Immunopathogenesis of Liver Injury During Hepatitis C Virus InfectionViral Immunology 2019; 32(3): 112 doi: 10.1089/vim.2018.0124
42
Tutik Sri Wahyuni, Adita Ayu permatasari, Tri Widiandani, Achmad Fuad, Aty Widyawaruyanti, Chie Aoki-Utsubo, Hak Hotta. Antiviral Activities of Curcuma Genus against Hepatitis C VirusNatural Product Communications 2018; 13(12): 1934578X1801301 doi: 10.1177/1934578X1801301204
43
Ee Hong Tam, Yu Peng, Megan Xin Yan Cheah, Chuan Yan, Tianshu Xiao. Neutralizing antibodies to block viral entry and for identification of entry inhibitorsAntiviral Research 2024; 224: 105834 doi: 10.1016/j.antiviral.2024.105834
44
Luís Jesuino de Oliveira Andrade, Alexandre Pithon Lins, Lorena Pithon Lins, Raymundo Paraná, Augusto Cesar Ferreira Lins. Hepatite C e tireoide2021; : 53 doi: 10.7476/9786586213737.0003
45
Xiaofeng Dai, Xuanhao Zhang, Kostya Ostrikov, Levon Abrahamyan. Host receptors: the key to establishing cells with broad viral tropism for vaccine productionCritical Reviews in Microbiology 2020; 46(2): 147 doi: 10.1080/1040841X.2020.1735992
46
Janelle Johnson, Holly Freedman, Michael Logan, Jason Alexander Ji-Xhin Wong, Darren Hockman, Chao Chen, Jianqi He, Michael R. Beard, Nicholas S. Eyre, Thomas F. Baumert, D. Lorne Tyrrell, John L. M. Law, Michael Houghton, J.-H. James Ou. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1Journal of Virology 2019; 93(22) doi: 10.1128/JVI.00810-19